Advertisement

Virchows Archiv

, Volume 427, Issue 3, pp 295–301 | Cite as

Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers

  • M. M. F. J. Tinnemans
  • M.-H. J. H. Lenders
  • F. C. S. Ramaekers
  • B. Schutte
  • G. P. M. ten Velde
  • S. S. Wagenaar
  • G. H. Blijham
Original Article

Abstract

In a series of 44 bronchial biopsies from patients suspected of having endobronchial lung carcinoma, the validity of proliferating cell nuclear antigen (PCNA) and Ki67 antigen as proliferative indicators was evaluated in ethanol fixed, paraffin embedded tissue. The percentages of cells positive for these markers were compared to the in vivo bromodeoxyuridine (BrdU) labelling index. A good correlation was found between PCNA immunoreactivity and BrdU labelling index, while Ki67-antigen expression showed a significant relation with BrdU labelling index and with PCNA expression. All three parameters showed a trend towards similar values for the individual cases. Based on the fact that Ki67 antigen is expressed in all cycling cells, whereas replicon-associated PCNA and BrdU only reflect the S-phase fraction, the differences between Ki67-antigen scores on the one hand and BrdU and PCNA scores on the other were smaller than expected. In order to determine the degree of concordance between immunohistochemically and flow cytometrically detected proliferation variables, BrdU incorporation was measured using both methods in duplicate bronchial specimens. Discrepancies in labelling indices were observed predominantly in DNA diploid samples, with consistently lower values in the flow cytometrically analysed specimens. In tumour specimens with an aneuploid DNA content, flow cytometric determination of proliferative activity yielded results similar to those obtained by tissue section examination. We conclude that the scores for PCNA and Ki67 antigen, immunohistochemically detected in ethanol fixed, paraffin embedded tissue reflect functional proliferative activity.

Key words

Bromodeoxyuridine Flow cytometry Immunohistochemistry Ki67 antigen Proliferating cell nuclear antigen 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baisch H, Gerdes J (1987) Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki67 and propidium iodide: Analysis of flow cytometry. Cell Tissue Kinet 20:387–391Google Scholar
  2. 2.
    Braun N, Papadopoulos T, Müller-Hermelink HK (1988) Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells. Virchows Arch [B] 56:25–33Google Scholar
  3. 3.
    Bravo R, Macdonald-Bravo H (1987) Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105:1549–1554Google Scholar
  4. 4.
    Bravo R, Frank R, Blundell RA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxillary protein to DNA polymerase-delta. Nature 326:515–517Google Scholar
  5. 5.
    Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489–503Google Scholar
  6. 6.
    Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB 1 and MIB 3) detect proliferating cells in micro-wave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedGoogle Scholar
  7. 7.
    Celis JE, Celis A (1985) Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferation cell nuclear antigen in cultured cells: subdivision of S-phase. Proc Natl Acad Sci USA 82:3262–3266Google Scholar
  8. 8.
    Coltrera MD, Skelly M, Gown AM (1993) Anti-PCNA antibody PC10 yields unreliable proliferation indices in routinely processed, deparaffinized, formalin-fixed tissue. Appl Immunohistochem 1:193–200Google Scholar
  9. 9.
    Connolly KM, Bogdanffy MS (1993) Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver; a dual-stain comparison with 5-bromo-2'-deoxyuridine. J Histochem Cytochem 41:1–6Google Scholar
  10. 10.
    Fontana D, Bellina M, Gubetta L, Fasolis G, Rolle L, Scoffone C, Porpiglia F, Colombo M, Tarabuzzi R, Leonardo E (1992) Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol 148:1149–1151Google Scholar
  11. 11.
    Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini B, Vignati S, Pingitore R, Angeletti A (1992) The expression of proliferating cell nulear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer 70:1520–1527Google Scholar
  12. 12.
    Galand P, Degraef C (1989) Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22:383–392Google Scholar
  13. 13.
    Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: comparison with flow cytometric analysis. Am J Pathol 134:733–739Google Scholar
  14. 14.
    Gelb AB, Kamel OW, LeBrun DP, Warnke RA (1992) Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/-cyclin monoclonal antibodies. Am J Pathol 141:1453–1458Google Scholar
  15. 15.
    Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710–1715Google Scholar
  16. 16.
    Guillaud P, DuManoir S, Seigneurin D (1989) Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7). Anal Cell Pathol 1:25–39Google Scholar
  17. 17.
    Hall PA, Woods AL (1990) Immunohistochemical markers of cell proliferation. Cell Tissue Kinet 23:505–522Google Scholar
  18. 18.
    Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294Google Scholar
  19. 19.
    Harper ME, Glynne-Jones E, Goddard L, Wilson DW, Matenhelia SS, Conn IG, Peeling WB, Griffiths K (1992) Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate 20:243–253Google Scholar
  20. 20.
    Humbert C, Santisteban MS, Usson Y, Robert-Nicoud M (1992) Intranuclear co-location of newly replicated DNA and PCNA by simultaneous immunofluorescent labelling and confocal microscopy in MCF-7 cells. J Cell Sci 103:97–103Google Scholar
  21. 21.
    Kelleher L, Magee HM, Dervan PA (1994) Evaluation of cell-proliferation antibodies reactive in paraffin sections. Appl Immunohistochem 2:164–170Google Scholar
  22. 22.
    Key G, Becker MH, Baron B, Duchrow M, Schlüter C, Flad HD, Gerdes J (1993) New Ki67-equivalent murine monoclonal antibodies MiB1–3 generated against bacterially expressed parts of the Ki67 cDNA containing three 62 base pair repetitive elements encoding for the Ki67 epitope. Lab Invest 68:629–636Google Scholar
  23. 23.
    Kirkwood B (1988) Essential of medical statistics. Blackwell, Oxford, pp 138–146Google Scholar
  24. 24.
    Kreipe H, Heidebrecht HJ, Hansen S, Röhlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R (1993) A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 142:3–9Google Scholar
  25. 25.
    Kubben FJGM, Peeters-Haesevoets A, Engels LGJB, Baeten CGMI, Schutte B, Arends JW, Stockbrugger RW, Blijham GH (1994) Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut 35:530–535Google Scholar
  26. 26.
    Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM (1986) Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209–219Google Scholar
  27. 27.
    Landberg G, Roos G (1991) Antibodies to proliferating cell nuclear antigen as S phase probes in flow cytometric cell cycle analysis. Cancer Res 51:4570–4574Google Scholar
  28. 28.
    Landberg G, Roos G (1993) Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation. Cell Prolif 26:427–437Google Scholar
  29. 29.
    Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P, Barbareschi M (1992) PCNA and Ki67-expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 45:416–419Google Scholar
  30. 30.
    Lohr F, Wenz F, Haas S, Flentje M (1995) Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry. Cell Prolif 28:93–104Google Scholar
  31. 31.
    Meyer JS, Nauert J, Koehm S (1989) Cell kinetics of human tumors by in vitro bromodeoxyruridine labeling. J Histochem Cytochem 37:1449–1454Google Scholar
  32. 32.
    Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM (1987) Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 168:475–486Google Scholar
  33. 33.
    Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517–520Google Scholar
  34. 34.
    Sasaki K, Kurosa A, Ishida Y (1993) Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects on the inhibition of DNA synthesis on it. Cytometry 14:876–882Google Scholar
  35. 35.
    Sasaki K, Kurosa A, Ishida Y, Matsuta M (1994) Estimation of S-phase fraction in tumor tissue sections by immunohistochemical staining of PCNA. J Histochem Cytochem 42:957–960Google Scholar
  36. 36.
    Schutte B, Reynders MMJ, Van Assche CLMVJ, Hupperets PSJG, Bosman FT, Blijham GH (1987) An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry 8:372–376Google Scholar
  37. 37.
    Schutte B, Tinnemans MMFJ, Pijpers GFP, Lenders M-HJH, Ramaekers FCS (in press) Three parameter flow cytometric analysis: simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Cytometry (in press)Google Scholar
  38. 38.
    Scott RJ, Hall PA, Haldane JS, Van Noorden S, Price Y, Lane DP, Wright NA (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173–187Google Scholar
  39. 39.
    Silvestrini R (1994) Cell kinetics: prognostic and therapeutic implications in human tumours. Cell Prolif 27:579–596Google Scholar
  40. 40.
    Steel GG (1977) Growth kinetics and tumors. Clarendon Press, OxfordGoogle Scholar
  41. 41.
    Suzuka I, Daidoji H, Matsuoka M, Kadowaki K, Takasaki Y, Nakane PK, Joriuchi T (1989) Gene for proliferating cell nuclear antigen (DNA polymerase-delta auxiliary protein) is present in both mammalian and higher plant genomes. Proc Natl Acad Sci USA 96:3189–3193Google Scholar
  42. 42.
    Tan CK, Castillo C, So AG, Downey KM (1986) An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem 261:310–316Google Scholar
  43. 43.
    Tinnemans MMFJ, Schutte B, Lenders M-HJH, Ten Velde GPM, Ramaekers FCS, Blijham GH (1993) Cytokinetic analysis of lung cancer by in vivo bromodeoxyruridine labelling. Br J Cancer 67:1217–1222Google Scholar
  44. 44.
    Tinnemans MMFJ, Lenders M-HJH, Ten Velde GPM, Blijham GH, Ramaekers FCS, Schutte B (1995) S-phase arrest of nutrient deprived lung cancer cells. Cytometry 19:326–333Google Scholar
  45. 45.
    Tsurusawa M, Fujimoto T (1995) Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells. Cytometry 20:146–153Google Scholar
  46. 46.
    Tungekar MF, Gatter KC, Dunnill MS, Mason DJ (1991) Ki-67 immunostaining and survival in operable lung cancer. Histopathology 19:545–550Google Scholar
  47. 47.
    TenVelde GPM, Schutte B, Reynders MMJ, Bosman FT, Blijham GH (1989) Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytologic specimens. Cytometry 10:807–810Google Scholar
  48. 48.
    VanDierendonck JH, Keijzer R, Van deVelde CJH, Cornelisse CJ (1989) Nuclear distribution of the Ki67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 49:2999–3006Google Scholar
  49. 49.
    VanDierendonck JH, Wijsman JH, Keijzer R, Van de Velde CJH, Cornelisse CJ (1991) Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am J Pathol 138:1165–1172Google Scholar
  50. 50.
    Verheijen R, Kuijpers HJH, Schlingeman RO, Boehmer HL, VanDriel R, Brakenhoff GJ, Ramaekers FCS (1989) Ki67 detects a nuclear matrix associated proliferation antigen. Part I. Intracellular localisation during interphase. J Cell Sci 92:123–130Google Scholar
  51. 51.
    Verheijen R, Kuijpers HJH, VanDriel R, Beck JLM, Van Dierendonck JH, Brakenhoff GJ, Ramaekers FCS (1989) Ki67 detects a nuclear matrix associated proliferation antigen. II. Localisation in mitotic cells and association with chromosomes. J Cell Sci 92:531–540Google Scholar
  52. 52.
    Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121–129Google Scholar
  53. 53.
    Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, Levison DA (1991) The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 19:21–27Google Scholar
  54. 54.
    Yu CC-W, Woods AL, Levison DA (1992) The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 24:121–131Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • M. M. F. J. Tinnemans
    • 1
  • M.-H. J. H. Lenders
    • 1
  • F. C. S. Ramaekers
    • 1
  • B. Schutte
    • 1
  • G. P. M. ten Velde
    • 2
  • S. S. Wagenaar
    • 3
  • G. H. Blijham
    • 4
  1. 1.Department of Molecular Cell Biology and GeneticsUniversity of LimburgMaastrichtThe Netherlands
  2. 2.Department of PulmonologyUniversity Hospital MaastrichtMaastrichtThe Netherlands
  3. 3.Department of PathologyOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands
  4. 4.Department of Internal MedicineUniversity Hospital UtrechtUtrechtThe Netherlands

Personalised recommendations